BCM
Boone Capital Management Portfolio holdings
AUM
$233M
This Quarter Return
+14.93%
1 Year Return
+15.17%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$279M
AUM Growth
+$279M
(+30%)
Cap. Flow
+$44.7M
Cap. Flow
% of AUM
16.03%
Top 10 Holdings %
Top 10 Hldgs %
89.43%
Holding
13
New
1
Increased
7
Reduced
1
Closed
–
Top Buys
| 1 |
Baxter International
BAX
|
$15.2M |
| 2 |
IDEAYA Biosciences
IDYA
|
$11.7M |
| 3 |
Enovis
ENOV
|
$5.64M |
| 4 |
Danaher
DHR
|
$5.13M |
| 5 |
Molina Healthcare
MOH
|
$4.25M |
Top Sells
| 1 |
Quanterix
QTRX
|
$1.35M |
Sector Composition
| 1 | Healthcare | 85.32% |
| 2 | Financials | 14.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Unum
UNM
$11.9B
| $40.9M | 14.68% | 857,565 | – | – |
|
|
2
Molina Healthcare
MOH
$9.8B
| $32.1M | 11.52% | 106,519 +14,107 | +15% | +$4.25M |
|
|
3
Baxter International
BAX
$12.7B
| $31.3M | 11.25% | 687,701 +333,258 | +94% | +$15.2M |
|
4
Cigna
CI
$80.3B
| $31M | 11.13% | 110,551 +7,928 | +8% | +$2.22M |
|
|
5
Enovis
ENOV
$1.77B
| $27.4M | 9.85% | 427,793 +88,035 | +26% | +$5.64M |
|
|
6
Danaher
DHR
$147B
| $26.4M | 9.47% | 109,910 +21,372 | +24% | +$5.13M |
|
7
Amgen
AMGN
$155B
| $18.5M | 6.65% | 83,499 +4,349 | +5% | +$966K |
|
8
Biogen
BIIB
$19.4B
| $17.9M | 6.43% | 62,877 +3,355 | +6% | +$956K |
|
9
AbbVie
ABBV
$372B
| $11.9M | 4.26% | 88,026 | – | – |
|
|
10
IDEAYA Biosciences
IDYA
$2.15B
| $11.7M | 4.19% | +496,433 | New | +$11.7M |
|
|
11
Quanterix
QTRX
$211M
| $11.3M | 4.06% | 501,144 -60,000 | -11% | -$1.35M |
|
|
CERE
12
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $9.54M | 3.42% | 300,000 | – | – |
|
13
TruBridge
TBRG
$300M
| $8.62M | 3.1% | 349,245 | – | – |
|